• Clinical Publications
• Medical Information
• Experts
• Media Resources

Medical Information

Cryocare® TCAP™ (Targeted Cryoablation of the Prostate™) is a minimally invasive prostate cancer new treatment that uses ice to destroy prostate cancer. -40°C temperature is instantly lethal to cancer, resulting in immediate prostate cancer cell death.

Cryocare TCAP is approved by Medicare as a primary treatment for prostate cancer. It's also approved as a treatment of prostate cancer for recurrent prostate cancer after any type of radiation.

Today over 350 published studies help document the clinical value of cryoablation as a prostate cancer treatment option. And recent 10 year data provides evidence of cryoablation's long-term durability. The Cryocare procedure has been performed on thousands of men by hundreds of doctors nationwide.

Sponsored by Endocare

Please log-in or register in order to submit comments.

Powered by AkoComment!